As a Strategic Hospital Advisor specializing in 340B, Sarah McHale works with 340B hospitals and grantees, providing analytical data and strategies focused on reducing overall pharmacy spend. She continually examines the market landscape to anticipate and interpret regulatory requirement changes, and provides guidance related to any HRSA, PBM, or pharmaceutical changes that may impact the 340B program. She provides consultative services around pharmacy reimbursement, invoicing, and flow of revenue with a targeted focus on 340B opportunities, and proactively identifies solutions to overcome any potential plan challenges.

Sarah has 9 years of experience in 340B program management and a 340B Apexus Certified Expert since 2019. Sarah earned a Bachelor of Business Administration (BBA) degree in Management from the University of the Incarnate Word in San Antonio, Texas.